Progress in Nanomedicine: Approved and Investigational Nanodrugs.

598 indexed citations
published 2017
Authors
Ventola Cl
Journal
PubMed

In The Last Decade

doi.org/w22700628 →

Countries where authors are citing Progress in Nanomedicine: Approved and Investigational Nanodrugs.

Specialization
Citations

This map shows the geographic impact of Progress in Nanomedicine: Approved and Investigational Nanodrugs.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Progress in Nanomedicine: Approved and Investigational Nanodrugs. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Progress in Nanomedicine: Approved and Investigational Nanodrugs. more than expected).

Fields of papers citing Progress in Nanomedicine: Approved and Investigational Nanodrugs.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Progress in Nanomedicine: Approved and Investigational Nanodrugs.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Progress in Nanomedicine: Approved and Investigational Nanodrugs..

About Progress in Nanomedicine: Approved and Investigational Nanodrugs.

This paper, published in 2017, received 598 indexed citations . Written by Ventola Cl covering the research area of Molecular Biology, Biomedical Engineering and Biomaterials. It is primarily cited by scholars working on Biomaterials (298 citations), Biomedical Engineering (251 citations) and Molecular Biology (194 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w22700628.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Involvement of Nitric Oxide in Biofilm Dispersal of Pseudomonas aeruginosaBreakdown of academic impact, for the paper PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to GefitinibBreakdown of academic impact, for the paper Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune ResponsesBreakdown of academic impact, for the paper Specific HIV integration sites are linked to clonal expansion and persistence of infected cellsBreakdown of academic impact, for the paper Research on Presence in Virtual Reality: A SurveyBreakdown of academic impact, for the paper A time delay neural network architecture for efficient modeling of long temporal contextsBreakdown of academic impact, for the paper Semantics: Primes and universais. By Anna Wierzbicka. Oxford & New York: Oxford University Press. 1996. Pp. xii, 500. $105.00.Breakdown of academic impact, for the paper Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020Breakdown of academic impact, for the paper Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen ActivatorBreakdown of academic impact, for the paper Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
Rankless by CCL
2026